ada.enesco, Author at European Medical Journal - Page 36 of 65

Biodegradable Electrodes Stimulate Brain Repair for Neurological Disorders

Flexible, biodegradable electrodes stimulate brain repair, offering safe, temporary treatment for neurological disorders, revolutionising patient care.

Digital Tools Enhance Genetic Testing for Hereditary Cancer Risk

A recent study has demonstrated the effectiveness of online screening and virtual patient education tools in improving hereditary cancer risk assessments

Prostate Cancer Recurrence Risk with Testosterone Therapy

These findings suggest that testosterone therapy can be safely administered to carefully selected men following radical prostatectomy without increasing the risk of biochemical recurrence.

Bariatric Surgery Reduces Pre-Diabetes to Diabetes Conversion Rates

A recent study highlights the long-term benefits of bariatric surgery in preventing the progression from pre-diabetes to Type 2 diabetes.

How Stress Worsens Allergies Through Immune System Disruption

Atopic dermatitis, an allergic skin condition characterised by inflammation and heightened IgE levels, is often worsened by psychological stress.

Tafamidis: A New Era in Transthyretin Amyloid Cardiomyopathy Management

Tafamidis reduces mortality and slows cardiac deterioration in ATTR-CM, improving imaging and clinical outcomes.

Daily Grape Juice May Protect Against Erectile Dysfunction

Consuming grape juice at least 5 times per week may reduce the risk of erectile dysfunction, especially in men over 40 years old.

Home High-Flow Therapy Offers Promise for COPD Recovery

Home high-flow therapy improves recovery for COPD patients after severe exacerbations, showing potential for better symptom control and reduced readmissions.

Cancer Screening Delays Among Asian American Women Linked to COVID-19 Fears

Fears of contracting COVID-19 are causing delays in cancer screening amongst Asian American women, study finds.

Wearable Technology Revolutionises Subclinical Leaflet Thrombosis Detection After TAVR

Innovative wearable ACG technology shows promise as a non-invasive diagnostic tool for SLT after TAVR.